Evidence map›Paper›PMID 34577575›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Fusion-Based Neutron Generator Production of Tc-99m and Tc-101: A Prospective Avenue to Technetium Theranostics.

Edward J Mausolf, Erik V Johnstone, Natalia Mayordomo, David L Williams, Eugene Yao Z Guan, Charles K Gary

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Quantitative assessment ofRadiological physics and technology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Developing a ChromatographicMolecules (Basel, Switzerland) · 2022
    Article
  8. Production Review of Accelerator-Based Medical Isotopes.Molecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Edward J MausolfInnovative Fuel Solutions LLC, North Las Vegas, NV 89031, USA.
Erik V JohnstoneInnovative Fuel Solutions LLC, North Las Vegas, NV 89031, USA.ORCID 0000-0001-7358-8085
Natalia MayordomoHelmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Resource Ecology, Bautzner Landstraße 400, 01328 Dresden, Germany.ORCID 0000-0003-4433-9500
David L WilliamsAdelphi Technology, Inc., Redwood City, CA 94063, USA.ORCID 0000-0002-8439-0290
Eugene Yao Z GuanAdelphi Technology, Inc., Redwood City, CA 94063, USA.
Charles K GaryAdelphi Technology, Inc., Redwood City, CA 94063, USA.ORCID 0000-0002-9636-5455
Adelphi Technology (United States) · USHelmholtz-Zentrum Dresden-Rossendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Presented are the results of

Indexed as

diagnosticfusionmedical isotopesmolybdenum-99neutron generatorradiopharmaceuticalsspecial nuclear material (SNM)technetium-99mtheranostic

Identifiers

PMID34577575
PMCPMC8467155
OpenAlexW3197678617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.